Opus Genetics Inc

IRDNASDAQ · USD
3.99USD0.00 (-2.21%)
1110

Opus Genetics Inc (IRD) Unusual Options Activity Today

Read more

Checking IRD unusual options activity helps you spot when traders are making outsized bets on Opus Genetics Inc before the broader market catches on. Unusual activity flags contracts trading at multiples of their average daily volume, often signaling informed money positioning ahead of a catalyst. Use our scanner to monitor IRD unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically means volume vastly exceeds open interest at a given strike, or total contract volume on a name spikes well above its norm. Watching IRD unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking IRD unusual options volume across calls and puts helps you separate hedging from genuinely speculative positioning, especially valuable around earnings, product launches, and macro events.

Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. The company offers Phentolamine Ophthalmic Solution for reversal of mydriasis, as well as is in Phase III clinical trials for presbyopia and dim light or night vision disturbances. Its lead retinal product candidate is APX3330, a small-molecule inhibitor of reduction oxidation effector factor-1 protein that has completed Phase II clinical trial for the treatment of diabetic retinopathy.

2026-12-18
Calls
2.50—4.104.101,000%02610.00%
5.00—0.200.20115%01,2140.00%
7.50—0.150.15187%010.00%
Puts
2.50—0.500.50321%040.00%
5.00—3.903.90846%00—
7.502.206.004.10314%00—

As of Nov 20, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →